We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
-13.93%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$106M
AUM Growth
-$29M
Cap. Flow
+$1.68M
Cap. Flow %
1.58%
Top 10 Hldgs %
93.01%
Holding
19
New
1
Increased
2
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
APLT
Applied Therapeutics
APLT
+$7.08M
2
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$1.33M
3
BTAI icon
BioXcel Therapeutics
BTAI
+$449K

Top Sells

Rank Stock Value
1
BX icon
Blackstone
BX
+$4.04M
2
KBA icon
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
+$3.14M

Sector Composition

Rank Sector Weight
1 Healthcare 92.65%
2 Financials 3.42%
3 Materials 1.97%
4 Communication Services 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$29.2M 27.41%
857,494
– –
CRBP icon
2
Corbus Pharmaceuticals
CRBP
$163M
$26.4M 24.84%
168,196
– –
APLT
3
DELISTED
Applied Therapeutics
APLT
$21M 19.72%
642,071
+175,000
+37% +$7.08M
ABEO icon
4
Abeona Therapeutics
ABEO
$336M
$6.01M 5.64%
114,391
– –
BX icon
5
Blackstone
BX
$105B
$3.65M 3.42%
80,000
-73,000
-48% -$4.04M
ENTX icon
6
Entera Bio
ENTX
$171M
$3.27M 3.08%
1,741,363
– –
EIGR
7
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.23M 3.04%
15,841
+4,166
+36% +$1.33M
AVXL icon
8
Anavex Life Sciences
AVXL
$232M
$2.28M 2.14%
724,205
– –
LUMN icon
9
Lumen
LUMN
$6.14B
$2.08M 1.95%
220,000
– –
XCUR icon
10
Exicure
XCUR
$10.8M
$1.89M 1.78%
8,519
– –
MTEM
11
DELISTED
Molecular Templates, Inc.
MTEM
$1.51M 1.42%
7,594
– –
ALDX icon
12
Aldeyra Therapeutics
ALDX
$91.7M
$1.41M 1.32%
569,405
– –
SNGX icon
13
Soligenix
SNGX
$5.27M
$1.32M 1.24%
3,286
– –
DOW icon
14
Dow Inc
DOW
$21.2B
$877K 0.82%
30,000
– –
CTVA icon
15
Corteva
CTVA
$59.5B
$705K 0.66%
30,000
– –
OTRK
16
DELISTED
Ontrak
OTRK
$655K 0.62%
478
– –
DD icon
17
DuPont de Nemours
DD
$19B
$512K 0.48%
11,950
– –
BTAI icon
18
BioXcel Therapeutics
BTAI
$25.9M
$447K 0.42%
+1,250
New +$449K
KBA icon
19
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$148M
– –
-96,000
Closed -$3.14M

Similar funds

AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return
V
ViaWealth Leawood, Kansas $180M AUM 20.16% 1-Year Est. Return

Knoll Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Knoll Capital Management held 19 positions worth $106M, down 21% from $135M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Knoll Capital Management's Q1 2020 filing shows 1 new, 2 increased, 1 reduced and 1 closed positions. Its largest new stake was BioXcel Therapeutics: 1,250 shares worth $447K. The largest sale was Blackstone, an estimated $4.04M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 87% a quarter earlier, followed by Financials and Materials.

  • Knoll Capital Management's largest Q1 2020 buy was BioXcel Therapeutics: 1,250 shares worth $447K.
  • Knoll Capital Management added most to Applied Therapeutics in Q1 2020, an estimated $7.08M increase.
  • Knoll Capital Management's biggest Q1 2020 reduction was Blackstone, cutting an estimated $4.04M.
  • Knoll Capital Management fully exited KraneShares Bosera MSCI China A 50 Connect Index ETF in Q1 2020, selling an estimated $3.14M.
  • Knoll Capital Management's ten largest holdings make up 93% of its $106M portfolio in Q1 2020.
  • Knoll Capital Management opened 1 new position and closed 1 in Q1 2020.
  • Knoll Capital Management's portfolio value fell 21% quarter-over-quarter to $106M.

Based on Knoll Capital Management's 13F filing for Q1 2020, filed 15 May 2020.